PMC Links for Books (Select 1484480) - PMC

Links from Books

Items: 1 to 20 of 29

<< First< Prev

Page of 2

Select item 100844991.

Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression

D Gareth Evans, Dorothy Halliday, Rupert Obholzer, Shazia Afridi, Claire Forde, Scott A Rutherford, Charlotte Hammerbeck-Ward, Simon K Lloyd, Simon M Freeman, Omar N Pathmanaban, Owen M Thomas, Roger D Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Timothy Lavin, Chay Paterson, Gillian Whitfield, Martin G McCabe, Patrick R Axon, Jane Halliday, Samuel Mackeith, Allyson Parry, English Specialist NF2 Research Group , Elaine F Harkness, Juliette Buttimore, Andrew T King

Neurooncol Adv. 2023 Jan-Dec; 5(1): vdad025. Published online 2023 Mar 11. doi: 10.1093/noajnl/vdad025

PMCID:: PMC10084499

Article PDF–272K

Select item 93144842.

Variation among DNA banking consent forms: points for clinicians to bank on

Samuel J. Huang, Laura M. Amendola, Darci L. Sternen

J Community Genet. 2022 Aug; 13(4): 389–397. Published online 2022 Jul 14. doi: 10.1007/s12687-022-00601-3

PMCID:: PMC9314484

Article PDF–776K

Select item 82820083.

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

Long-Sheng Chang, Janet L. Oblinger, Abbi E. Smith, Marc Ferrer, Steven P. Angus, Eric Hawley, Alejandra M. Petrilli, Roberta L. Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan K. Bessler, Xiaohu Zhang, Rajarshi Guha, Craig Thomas, Sarah S. Burns, Thomas S. K. Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A. H. Dixon, Andrea Masters, David R. Jones, Charles W. Yates, Stephen J. Haggarty, Salvatore La Rosa, D. Bradley Welling, Anat O. Stemmer-Rachamimov, Scott R. Plotkin, James F. Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernandez-Valle, Gary L. Johnson, Jaishri O. Blakeley, D. Wade Clapp, on behalf of the Synodos for NF2 Consortium

PLoS One. 2021; 16(7): e0252048. Published online 2021 Jul 15. doi: 10.1371/journal.pone.0252048

PMCID:: PMC8282008

Article PDF–4.5M

Select item 82488504.

Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution

Claire Forde, Andrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, Simon K Lloyd, Simon R Freeman, Omar N Pathmanaban, Emma Stapleton, Owen M Thomas, Roger D Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Simon Kerrigan, Miriam J Smith, Martin G McCabe, Elaine F Harkness, D Gareth Evans

Neuro Oncol. 2021 Jul; 23(7): 1113–1124. Published online 2020 Dec 18. doi: 10.1093/neuonc/noaa284

PMCID:: PMC8248850

Article PDF–372K

Select item 65634295.

Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene

D. Gareth Evans, Andrew J. Wallace, Claire Hartley, Simon R. Freeman, Simon K. Lloyd, Owen Thomas, Patrick Axon, Charlotte L. Hammerbeck‐Ward, Omar Pathmanaban, Scott A. Rutherford, Mark Kellett, Roger Laitt, Andrew T. King, Jemma Bischetsrieder, Jaishri Blakeley, Miriam J. Smith

Laryngoscope. 2019 Apr; 129(4): 967–973. Published online 2018 Oct 16. doi: 10.1002/lary.27554

PMCID:: PMC6563429

Article PDF–195K

Select item 59099376.

Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation

Katrina A. Morris, John F. Golding, Patrick R. Axon, Shazia Afridi, Claire Blesing, Rosalie E. Ferner, Dorothy Halliday, Raj Jena, Pieter M. Pretorius, the UK NF2 Research group, D. Gareth Evans, Martin G. McCabe, Allyson Parry

Neurooncol Pract. 2016 Dec; 3(4): 281–289. Published online 2016 Jan 7. doi: 10.1093/nop/npv065

PMCID:: PMC5909937

Article PDF–1.3M

Select item 57405517.

Genetic Severity Score predicts clinical phenotype in NF2

Dorothy Halliday, Beatrice Emmanouil, Pieter Pretorius, Samuel MacKeith, Sally Painter, Helen Tomkins, D Gareth Evans, Allyson Parry

J Med Genet. 2017 Oct; 54(10): 657–664. Published online 2017 Aug 28. doi: 10.1136/jmedgenet-2017-104519

PMCID:: PMC5740551

Article PDF–303K

Select item 57101798.

Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults

Omar N. Pathmanaban, Katherine V. Sadler, Ian D. Kamaly-Asl, Andrew T. King, Scott A. Rutherford, Charlotte Hammerbeck-Ward, Martin G. McCabe, John-Paul Kilday, Christian Beetz, Nicola K. Poplawski, D. Gareth Evans, Miriam J. Smith

JAMA Neurol. 2017 Sep; 74(9): 1123–1129. Prepublished online 2017 Jul 31. Published online 2017 Sep 11. doi: 10.1001/jamaneurol.2017.1406

PMCID:: PMC5710179

Article

Select item 52257909.

Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies

M. Ruggieri, A.D. Praticò, A. Serra, L. Maiolino, S. Cocuzza, P. Di Mauro, L. Licciardello, P. Milone, G. Privitera, G. Belfiore, M. Di Pietro, F. Di Raimondo, A. Romano, A. Chiarenza, M. Muglia, A. Polizzi, D.G. Evans

Acta Otorhinolaryngol Ital. 2016 Oct; 36(5): 345–367. doi: 10.14639/0392-100X-1093

PMCID:: PMC5225790

Article PDF–1.2M

Select item 520085310.

Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis

Miriam J. Smith, Naomi L. Bowers, Michael Bulman, Carolyn Gokhale, Andrew J. Wallace, Andrew T. King, Simon K.L. Lloyd, Scott A. Rutherford, Charlotte L. Hammerbeck-Ward, Simon R. Freeman, D. Gareth Evans

Neurology. 2017 Jan 3; 88(1): 87–92. doi: 10.1212/WNL.0000000000003418

Correction in:: Neurology. 2017 Jul 11; 89(2): 215.

PMCID:: PMC5200853

Article PDF–164K

Select item 497466411.

A critical role for NF2 and the Hippo pathway in branching morphogenesis

Antoine Reginensi, Leonie Enderle, Alex Gregorieff, Randy L. Johnson, Jeffrey L. Wrana, Helen McNeill

Nat Commun. 2016; 7: 12309. Published online 2016 Aug 2. doi: 10.1038/ncomms12309

PMCID:: PMC4974664

Article PDF–3.8M

Select item 481664212.

Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2

Scott R. Plotkin, Anat O. Stemmer-Rachamimov, Fred G. Barker, II, Chris Halpin, Timothy P. Padera, Alex Tyrrell, A. Gregory Sorensen, Rakesh K. Jain, Emmanuelle di Tomaso

N Engl J Med. Author manuscript; available in PMC 2016 Mar 31.

Published in final edited form as: N Engl J Med. 2009 Jul 23; 361(4): 358–367. Published online 2009 Jul 8. doi: 10.1056/NEJMoa0902579

PMCID:: PMC4816642

Article PDF–423K

Select item 259800213.

Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation‐dependent probe amplification

D Gareth R Evans, R T Ramsden, A Shenton, C Gokhale, N L Bowers, S M Huson, G Pichert, A Wallace

J Med Genet. 2007 Jul; 44(7): 424–428. Published online 2007 Feb 16. doi: 10.1136/jmg.2006.047753

PMCID:: PMC2598002

Article PDF–147K

Select item 256322314.

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

D G R Evans, J M Birch, R T Ramsden, S Sharif, M E Baser

J Med Genet. 2006 Apr; 43(4): 289–294. Published online 2005 Sep 9. doi: 10.1136/jmg.2005.036319

PMCID:: PMC2563223

Article PDF–138K

Select item 237441415.

Neurofibromatosis 2, radiosurgery and malignant nervous system tumours

M E Baser, D G R Evans, R K Jackler, E Sujansky, A Rubenstein

Br J Cancer. 2000 Feb; 82(4): 998. doi: 10.1054/bjoc.1999.1030

PMCID:: PMC2374414

Summary PDF–24K

Select item 199410216.

Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature

Anandh Balasubramaniam, Patrick Shannon, Mojgan Hodaie, Normand Laperriere, Howard Michaels, Abhijit Guha

Neuro Oncol. 2007 Oct; 9(4): 447–453. doi: 10.1215/15228517-2007-027

PMCID:: PMC1994102

Article PDF–8.4M

Select item 191491017.

Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

D. M. Parry, M. M. MacCollin, M. I. Kaiser-Kupfer, K. Pulaski, H. S. Nicholson, M. Bolesta, R. Eldridge, J. F. Gusella

Am J Hum Genet. 1996 Sep; 59(3): 529–539.

PMCID:: PMC1914910

Summary Page Browse PDF–1.8M

Select item 173868918.

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

J Rowe, M Radatz, L Walton, T Soanes, J Rodgers, A Kemeny

J Neurol Neurosurg Psychiatry. 2003 Sep; 74(9): 1288–1293. doi: 10.1136/jnnp.74.9.1288

PMCID:: PMC1738689

Summary PDF–155K

Select item 173609219.

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2

M Baser, L Kuramoto, R Woods, H Joe, J Friedman, A Wallace, R Ramsden, S Olschwang, E Bijlsma, M Kalamarides, L Papi, R Kato, J Carroll, C Lazaro, F Joncourt, D Parry, G Rouleau, D Evans

J Med Genet. 2005 Jul; 42(7): 540–546. doi: 10.1136/jmg.2004.029504

PMCID:: PMC1736092

Summary PDF–99K

Select item 173590020.

Multiple meningiomas: differential involvement of the NF2 gene in children and adults

D Evans, C Watson, A King, A Wallace, M Baser

J Med Genet. 2005 Jan; 42(1): 45–48. doi: 10.1136/jmg.2004.023705

PMCID:: PMC1735900

Summary PDF–61K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 1 to 20 of 29

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity